Cargando…
Autoreactivity of Broadly Neutralizing Influenza Human Antibodies to Human Tissues and Human Proteins
Broadly neutralizing monoclonal antibodies (bNAbs) against conserved domains in the influenza hemagglutinin are in clinical trials. Several next generation influenza vaccines designed to elicit such bNAbs are also in clinical development. One of the common features of the isolated bNAbs is the use o...
Autores principales: | Khurana, Surender, Hahn, Megan, Klenow, Laura, Golding, Hana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600923/ https://www.ncbi.nlm.nih.gov/pubmed/33049994 http://dx.doi.org/10.3390/v12101140 |
Ejemplares similares
-
Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies
por: Bajic, Goran, et al.
Publicado: (2019) -
Preclinical evaluation of bacterially produced RSV-G protein vaccine: Strong protection against RSV challenge in cotton rat model
por: Fuentes, Sandra, et al.
Publicado: (2017) -
Repeat vaccination reduces antibody affinity maturation across different influenza vaccine platforms in humans
por: Khurana, Surender, et al.
Publicado: (2019) -
Protective antigenic sites in respiratory syncytial virus G attachment protein outside the central conserved and cysteine noose domains
por: Lee, Jeehyun, et al.
Publicado: (2018) -
Human Antibody Repertoire following Ebola Virus Infection and Vaccination
por: Fuentes, Sandra, et al.
Publicado: (2020)